Chloramphenicol, a lipid-soluble drug, and trimethoprim were concentrated three-to fourfold by cytoplasts. An unusual finding was that trimethroprim, unlike other tested antibiotics, was accumulated by cytoplasts more readily at 25°C than at 3rC. After an initial rapid association with cytoplasts, cell-associated imipenem declined progressively with time. Clindamycin and two macrolide antibiotics (roxithromycin, erythromycin) were concentrated 7-to 14-fold by cytoplasts. This indicates that cytoplasmic granules are not essential for accumulation of these drugs. Adenosine inhibited cytoplast uptake of clindamycin, which enters intact phagocytic cells by the membrane nucleoside transport system. Roxithromycin uptake by cytoplasts was inhibited by phagocytosis, which may reduce the number of cell membrane sites available for the transport of macrolides. These studies have added to our understanding of uptake mechanisms for antibiotics which are highly concentrated in phagocytes.
Interactions between antibiotics and leukocytes may influence the outcome of therapy for bacterial infections. Any effect on the fate of bacteria ingested by phagocytic cells would be especially important (12) . Obviously, entry of antibiotics into these cells is required for activity against intraphagocytic organisms. We have previously examined the uptake of 17 antimicrobial agents by polymorphonuclear neutrophilic leukocytes (PMN) and mononuclear phagocytes (6, 7, 10, 11, 13, 17) . Human PMN are the crucial phagocytic cells in protection against most bacterial infections. Unfortunately, we found that only a few antibiotics enter these neutrophils efficiently (11, 17) . Clindamycin and macrolide antibiotics (erythromycin, roxithromycin) are avidly concentrated in PMN by means of active membrane transport mechanisms (11, 17, 20 ; W. L. Hand, Antimicrobic Newsl. 5:53-58, 1988). The entry of clindamycin into PMN is via the cell membrane nucleoside transport system (20) . Despite considerable effort, we have not identified the specific transport mechanism(s) for macrolide entry into neutrophils (11) .
Enucleated human PMN (PMN cytoplasts) contain no nuclei and very few granules but exhibit many characteristics of intact cells (5, 18, 21) . Antibiotic entry into these cytoplasts will be independent of concentration within granules. This is important since certain antibiotics (weak bases) have been considered lysosomatropic agents, which accumulate within the granules of leukocytes (3, 14, 15 4) velocity gradient centrifugation technique which we previously described in detail (6-11, 13, 17, 20 The impact of phagocytosis and other cell membrane stimulation on antibiotic entry into PMN and cytoplasts was o w 4 0 0 determined as we have previously described (9, 11, 20 (8, 20) . To determine whether this was also true in PMN cytoplasts, we evaluated the ability of adenosine (Sigma) to inhibit clindamycin uptake. The nucleoside was preincubated with PMN cytoplasts for 20 min before determination of radiolabeled antibiotic uptake.
RESULTS
Characteristics of cell population. At least 97% of the granulocytes were neutrophils. Because >90%o of these cells were PMN, this cell population is referred to as PMN. Greater than 95% of these phagocytic cells were viable, as judged by trypan blue exclusion.
The recovery of cytoplasts was 88%, compared with the number of PMN in the initial preparation. These PMN cytoplasts contained no nuclei and relatively few granules (,B-glucuronidase and lysozyme activity were -10% of whole-cell values). The mean volumes of 2 x 106 cells (32 experiments) were 0.0009 ml for PMN and 0.00022 ml for cytoplasts. In other words, the cytoplast volume was 24% of the intact cell volume. In contrast, the cytoplasmic lactate dehydrogenase content of the cytoplasts was 39% of that in PMN. This indicates that -60% of the whole-cell PMN volume is cytoplasm, whereas the nucleus and granules occupy -40% of the intracellular space.
Antibiotic entry into human PMN and PMN cytoplasts. The uptakes of eight radiolabeled antibiotics by PMN cytoplasts are shown in Table 1 . The relative uptakes of these antibiotics in cytoplasts were generally similar to what we have previously demonstrated in PMN (9, 11, 17, 20) . For instance, penicillin G penetrated both intact phagocytic cells (9, 17, 20) and cytoplasts poorly. The cellular concentration of this drug was lower than the extracellular level (C/E = 0.6 to 0.8). Experiments with imipenem, a novel ,-lactam (carbapenem) antibiotic, provided some unusual findings. This antimicrobial agent rapidly and avidly associated with cytoplasts (C/E = 13 at 5 min), but cell-associated antibiotic declined steadily during the incubation period. This phenomenon was previously observed in studies of imipenem uptake by human PMN and monocytes (10, 11) .
Metronidazole achieved a concentration in cytoplasts equal to or somewhat less than the extracellular concentration (C/E = 0.5 to 1.1), which is what we observed in intact PMN (11) . Chloramphenicol (a lipid-soluble drug) was concentrated threefold in cytoplasts, much like intact PMN (17) . Trimethoprim was concentrated approximately threefold by cytoplasts, and the characteristics of the entry process differed from those of the other drugs we evaluated (see below).
Clindamycin and two macrolide antibiotics (roxithromycin and erythromycin propionate) were markedly concentrated by cytoplasts. The decreased uptake of these antibiotics noted at 60 min was probably due to some deterioration of the cytoplasts with prolonged incubation. Uptake of roxithromycin by PMN cytoplasts (C/E = 14) was greater than that of any other antibiotic, just as it was in intact neutrophils (Table 2) (11).
In Table 2 , we compared the uptakes of these eight radiolabeled antibiotics by intact human PMN and cytoplasts. Several points are of interest. Uptake by cytoplasts of those antibiotics (clindamycin, macrolides) which enter by active membrane transport and become highly concentrated in phagocytes was >50 to 100% of that observed in intact PMN (9, 11, 17) . Trimethoprim accumulation by intact PMN was greater than that by cytoplasts, although the cellular concentrations were higher at 25°C in both cell preparations (11) . Finally, cell-associated imipenem was greater in cytoplasts than in PMN. In both cytoplasts and intact PMN, the cell-associated radiolabel declined with time (11) .
Characterization of antibiotic uptake. We established the environmental and metabolic requirements of the uptake process for three antibiotics (clindamycin, roxithromycin, trimethoprim) which achieve high concentrations within cytoplasts. As shown in intact PMN (17, 20) greater at 37°C than at 25°C. The effect of environmental temperature on trimethoprim accumulation by cytoplasts was quite surprising. There was a greater intracellular concentration of this antibiotic at 25°C than at 37°C (Table 3) . This inverse temperature-uptake relationship with trimethoprim also occurs in intact PMN (11) and was not observed with any of the other antibiotics we have studied (11, 17 ; data not shown). Next, we determined the effects of metabolic inhibitors on the uptake of clindamycin and roxithromycin by cytoplasts. Neither cyanide, an inhibitor of oxidative metabolism, nor fluoride, which inhibits glycolysis, had any definite effect on entry of clindamycin into cytoplasts. Cyanide had no influence on roxithromycin uptake, but at 30 min fluoride (10-' M) was slightly inhibitory to entry of the drug (C/E of 12.7 versus control of 15.4, P = 0.04).
We previously showed that ingestion of microbial particles (but not stimulation with ConA) decreased entry of roxithromycin into PMN (11) . In the present study, we found that exposure to microbial particles (S. aureus, zymosan) inhibited roxithromycin uptake by cytoplasts as it had in neutrophils (Table 4) . Unlike the experiments with PMN, ConA stimulation of cytoplasts also reduced uptake of roxithromycin.
Clindamycin enters intact phagocytic cells by means of the cell membrane nucleoside (adenosine) transport system (8, 20) . To determine whether this transport system also accounts for clindamycin uptake in cytoplasts, we attempted to block entry of the antibiotic with adenosine (competitive inhibition). At a concentration of 1l-' M, adenosine inhibited clindamycin uptake throughout the incubation period (Table 5) .
DISCUSSION
Human PMN cytoplasts, which have no nuclei and only a few granules, maintain many of the cell membrane-associated functions of intact neutrophils (5, 18, 21) . Studies of radiolabeled antibiotic uptake in PMN cytoplasts yielded results similar to those we observed in intact cells (9, 11, 17, 20 ; W. L. Hand, Antimicrobic Newsl. 5:53-58, 1988). Specifically, antibiotics which are highly concentrated in PMN also achieve high levels in cytoplasts. Thus, clindamycin, macrolides (roxithromycin, erythromycin), and trimethoprim entered cytoplasts in a very efficient fashion. Chloramphenicol, a lipid-soluble drug, was concentrated approximately threefold in cytoplasts, just as it is in whole cells. Drugs such as penicillin G and metronidazole do not enter either cytoplasts or intact phagocytic cells well.
An interesting finding was that imipenem rapidly and avidly associated with cytoplasts, followed by a progressive decline in cell-associated drug during the incubation period. This was similar to what we found in studies with intact PMN (11) . The basis for this phenomenon is uncertain, but possible explanations can be noted. First, the antibiotic may simply bind to the cell membrane and then dissociate over time. Second, the radiolabeled antibiotic (N-formimidoyl thienamycin) may be metabolized or altered by a cellular inactivation mechanism which is not inhibited by the cilastatin component of the drug combination (16) .
Other investigators have reported that clindamycin enters the isolated lysosomes of human PMN (14, 15 Next, we examined the characteristics of the uptake process for those antibiotics which were highly concentrated in cytoplasts. Trimethoprim accumulation by cytoplasts exhibited the same inverse temperature-uptake properties that we observed in intact PMN (11) . The cellular concen- We previously showed that the uptake of clindamycin and macrolide antibiotics by phagocytic cells was by active membrane transport (7, 8, 11, 13, 17, 20 ; W. L. Hand, Antimicrobic Newsl. 5:53-58, 1988). As is true in intact PMN (17, 20) , uptake of cindamycin by cytoplasts was dependent on cell viability and a physiologic environmental temperature. Thus, uptake of clindamycin was greater at 37°C than at 25°C. The effects of metabolic inhibitors on clindamycin and macrolide uptake by cytoplasts were also studied. Neither cyanide, an inhibitor of mitochondrial oxidative metabolism, nor fluoride, which blocks glycolysis, altered cindamycin uptake by cytoplasts under the conditions of this study. However, roxithromycin entry into cytoplasts was slightly inhibited by fluoride.
Clindamycin enters phagocytic cells (PMN and macrophages) by means of the cell membrane nucleoside (adenosine) transport system (8, 20) . We performed experiments to determine whether this was also true in cytoplasts. Adenosine inhibited the uptake of clindamycin by cytoplasts, presumably by competitive inhibition at membrane transport receptor sites.
Roxithromycin uptake by human PMN was inhibited by phagocytosis of zymosan and S. aureus (11) . This is probably the result of a reduction in the number of cell membrane sites available for the binding or transport of roxithromycin. Uptake of roxithromycin by cytoplasts was also inhibited by exposure to microbial particles and ConA, a lectin which might interfere with the binding of macrolides to membrane receptors.
In summary, these studies with PMN cytoplasts have added to our knowledge of antibiotic uptake mechanisms in phagocytes. The mechanisms for uptake of antibiotics which are highly concentrated in phagocytic cells appear to be intact in cytoplasts. This would suggest that accumulation of these drugs proceeds independently of granule function.
